APA (7th ed.) Citation

S, F., M, v. d. L., JJ, S., RAC, R., & ST, d. B. (2023). Study protocol of the HD-MED study aiming to personalize drug treatment in Huntington's disease: A longitudinal, observational study to assess medication use and efficacy in relation to pharmacogenetics. Therapeutic advances in rare disease, 4, 26330040231204643. https://doi.org/10.1177/26330040231204643

Chicago Style (17th ed.) Citation

S, Feleus, van der Lee M, Swen JJ, Roos RAC, and de Bot ST. "Study Protocol of the HD-MED Study Aiming to Personalize Drug Treatment in Huntington's Disease: A Longitudinal, Observational Study to Assess Medication Use and Efficacy in Relation to Pharmacogenetics." Therapeutic Advances in Rare Disease 4 (2023): 26330040231204643. https://doi.org/10.1177/26330040231204643.

MLA (9th ed.) Citation

S, Feleus, et al. "Study Protocol of the HD-MED Study Aiming to Personalize Drug Treatment in Huntington's Disease: A Longitudinal, Observational Study to Assess Medication Use and Efficacy in Relation to Pharmacogenetics." Therapeutic Advances in Rare Disease, vol. 4, 2023, p. 26330040231204643, https://doi.org/10.1177/26330040231204643.